January 5, 2018 / 9:14 AM / a year ago

BRIEF-Shenzhen Hepalink Pharmaceutical And Unit SPL To Invest In U.S. Firm Curemark LLC

Jan 5 (Reuters) - Shenzhen Hepalink Pharmaceutical Co Ltd :

* SAYS IT AND UNIT SPL PLAN TO INVEST IN U.S. FIRM CUREMARK LLC, TO OWN 3.63 PERCENT OF CUREMARK AFTER TRANSACTION Source text in Chinese: bit.ly/2AuYaxe Further company coverage: (Reporting by Hong Kong newsroom)

0 : 0
  • narrow-browser-and-phone
  • medium-browser-and-portrait-tablet
  • landscape-tablet
  • medium-wide-browser
  • wide-browser-and-larger
  • medium-browser-and-landscape-tablet
  • medium-wide-browser-and-larger
  • above-phone
  • portrait-tablet-and-above
  • above-portrait-tablet
  • landscape-tablet-and-above
  • landscape-tablet-and-medium-wide-browser
  • portrait-tablet-and-below
  • landscape-tablet-and-below